1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Lido - and with copay?

Discussion in 'Gensco Laboratories' started by Anonymous, Feb 23, 2015 at 5:11 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Anyone know much about this? Just heard about it in passing - didn't think much of it and then I saw that they have some kind of copay program that seems expesnive, albeit poorly executed.

    Interesting idea - but this product seems pretty ho-hum. This company also has a homeopathic Rx.... :/